Immunogenicity and safety of the live-attenuated tetravalent dengue vaccine (TAK-003) co-administered with recombinant 9-valent human papillomavirus vaccine

Impact of Dengue on Pregnancy

Vaccination strategies, public health impact and cost-effectiveness of dengue vaccine TAK-003: A modelling case study in Thailand

Antibiotic Use in Pediatric Dengue Cases in Taiwan: A National Administrative Database Analysis

TAK-003: Development of a tetravalent dengue vaccine

Operational challenges and lessons learned from conducting febrile surveillance in a long-term randomized dengue vaccine trial in Latin America and Asia-Pacific

Estimated efficacy of TAK-003 against asymptomatic dengue infection in children/adolescents participating in the DEN-301 trial in Asia Pacific and Latin America

Pregnancy outcomes following unintentional exposure to TAK-003, a live-attenuated tetravalent dengue vaccine

Immunogenicity, safety, and efficacy of a tetravalent dengue vaccine in children and adolescents: an analysis by age group

Efficacy and safety of a tetravalent dengue vaccine (TAK-003) in children with prior Japanese encephalitis or yellow fever vaccination

Early onset of protection of the TAK-003 dengue vaccine: Data from the DEN-301 clinical trial

Harmonization of vaccine ligand binding assays validation